Welcome to the Treatment Induced Nausea and Vomiting Study
The main goal of the Genomic Underpinnings for Breast Cancer Treatment Induced Nausea and Vomiting or what we like to call the Treatment Induced Nausea and Vomiting study (TINV) is to understand why some women with breast cancer experience nausea and vomiting from their treatments, and others do not.
Recent Updates
Hello! Below you will find recent updates for the TINV study. Read our Newsletters, past articles, and other updates.
We need your help! We are looking for volunteers to help us with a new study, the Microbiome Study. Would you like to take part in a feasibility research study that will allow us to expand our understanding of the relationship that the microbiome plays in nausea and vomiting? Of course you are asking WHY? Click here to learn more!
Krista and Katie will both be graduating from Pitt's School of Nursing with their BSN April 2023! Krista is planning to work in an Adult Intensive Care Unit after graduation while Katie is planning to work in a Neonatal Intensive Care Unit. Good luck to them both and we will miss them!
Recently, we have received funding to examine covid-related outcomes in the TINV study. This is why you may have noticed that there are more covid-related questions on the survey now. Thank you for your time answering these questions!
